In accordance with this reasoning, a more efficient response of antiviral CD8 T cells specific for a viral peptide, here shown for the immunodominant IE1 peptide presented by the MHC-I molecule Ld (51–53), was seen as a trend at 6 weeks after infection with the mutant virus. This evidence concerns the gene CD8A and infection.